Home › Trial NCT04809012
Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid Tumors
- Trial IDNCT04809012
- StatusWithdrawn
- PhasePhase 2
- Study typeInterventional
- SponsorSorrento Therapeutics, Inc.
- Enrollment—
- Start date2021-06
- ConditionsSolid Tumor · Refractory Tumor · Relapsed Solid Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.